Yuan DL - Search Results

1

PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells.

Yang LL, Zhang XK, Cao Y, Shi LY, Xie SY, Yang YJ, Wu SJ, Sun HZ, Tang XJ, Yuan DL, Zhang D, Xu XF, Li Q, Ying XY. Yang LL, et al. Among authors: yuan dl. Med Oncol. 2024 Oct 14;41(11):273. doi: 10.1007/s12032-024-02315-7. Med Oncol. 2024. PMID: 39400626

2

LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p.

Zhao Y, Yuan D, Zhu D, Xu T, Huang A, Jiang L, Liu C, Qian H, Bu X. Zhao Y, et al. J Ovarian Res. 2021 Aug 28;14(1):109. doi: 10.1186/s13048-021-00857-2. J Ovarian Res. 2021. PMID: 34454554 Free PMC article.

3

Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.

Zhang L, Qian H, Sha M, Luan Z, Lin M, Yuan D, Li X, Huang J, Ye L. Zhang L, et al. PLoS One. 2016 Oct 13;11(10):e0164838. doi: 10.1371/journal.pone.0164838. eCollection 2016. PLoS One. 2016. PMID: 27736969 Free PMC article.

4

Icariside II suppresses the tumorigenesis and development of ovarian cancer by regulating miR-144-3p/IGF2R axis.

Yuan D, Guo T, Qian H, Ge H, Zhao Y, Huang A, Wang X, Cao X, Zhu D, He C, Yu H. Yuan D, et al. Drug Dev Res. 2022 Sep;83(6):1383-1393. doi: 10.1002/ddr.21967. Epub 2022 Jul 9. Drug Dev Res. 2022. PMID: 35808943

5

A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma.

Liu F, Yuan D, Liu X, Zhuo S, Liu X, Sheng H, Sha M, Ye J, Yu H. Liu F, et al. Discov Oncol. 2023 Jun 12;14(1):96. doi: 10.1007/s12672-023-00711-5. Discov Oncol. 2023. PMID: 37306828 Free PMC article.

6

Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression.

Zhang LX, Liu ZN, Ye J, Sha M, Qian H, Bu XH, Luan ZY, Xu XL, Huang AH, Yuan DL, Wu YQ, Wang XX, Wang J, Huang JX, Ye LH. Zhang LX, et al. Among authors: yuan dl. Cell Biol Int. 2014 May;38(5):639-46. doi: 10.1002/cbin.10244. Epub 2014 Feb 5. Cell Biol Int. 2014. PMID: 24446394

7

Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.

Guo T, Yuan D, Zhang W, Zhu D, Xiao A, Mao G, Jiang W, Lin M, Wang J. Guo T, et al. Hum Cell. 2021 Mar;34(2):579-587. doi: 10.1007/s13577-020-00469-w. Epub 2021 Jan 5. Hum Cell. 2021. PMID: 33400246

8

SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway.

Ke M, Xu J, Ouyang Y, Chen J, Yuan D, Guo T. Ke M, et al. Transl Oncol. 2024 Nov;49:102088. doi: 10.1016/j.tranon.2024.102088. Epub 2024 Aug 20. Transl Oncol. 2024. PMID: 39167956 Free PMC article.

9

Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3.

Zhu D, Yuan D, Guo R, Zhang L, Guo T, Zhao Y, Wang J, Chen X, Qian H, Ge H. Zhu D, et al. Oncol Lett. 2019 Jul;18(1):402-410. doi: 10.3892/ol.2019.10321. Epub 2019 May 6. Oncol Lett. 2019. PMID: 31289511 Free PMC article.

10

Expression of lncRNA NEAT1 in endometriosis and its biological functions in ectopic endometrial cells as mediated via miR-124-3p.

Yuan D, Zhu D, Yin B, Ge H, Zhao Y, Huang A, Wang X, Cao X, Xia N, Qian H. Yuan D, et al. Genes Genomics. 2022 May;44(5):527-537. doi: 10.1007/s13258-021-01184-y. Epub 2022 Jan 30. Genes Genomics. 2022. PMID: 35094286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters